ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Bioventus Inc

Bioventus Inc (BVS)

8,95
-0,09
(-1,00%)
Geschlossen 09 Juni 10:00PM
8,84
-0,11
(-1,23%)
Nach Börsenschluss: 11:45PM

Bioventus Inc (BVS) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
8,84
( -2,21% )
Gebot
8,79
Fragen
9,06
Volumen
480.528
8,94 Tagesbereich 9,19
5,81 52-Wochen-Bereich 11,2493
Marktkapitalisierung
Handelsende
9,04
Handelsbeginn
9,08
Letzte Trade
3
@
8.9674
Letzter Handelszeitpunkt
Finanzvolumen
US$ 4.346.156
VWAP
9,0445
Durchschnittliches Volumen (3 Mio.)
US$ 555.160
Ausgegebene Aktien
67.748.048
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
22,43
Gewinn pro Aktie (EPS)
0,4
Erlöse (LTM)
576,3M
Nettogewinn (LTM)
28,48M

Über Bioventus Inc

Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve sti... Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain, and TalisMann provides stimulation to the targeted peripheral nerve, as well as XCELL PRP System, a benchtop device that processes whole blood to produce high-yield PRP with a 10-minute single-spin cycle. It also offers precision bone resection for patients with degenerative spine conditions and spinal deformities, as well as enables precision ultrasonic neuro and general surgery to address brain tumors and pathologies of the liver and other organs; and bone graft substitutes, including various products that facilitate optimal bone fusion. In addition, the company provides neXus, an ultrasonic surgical system; BoneScalpel, a surgical solution enabling precise cuts in hard tissue; BoneScalpel Access, for bone removal with visualization; SonaStar system, a precise ablation and removal of soft tissue; SonaStar Elite handpiece and accessories; SonicOne, an ultrasonic cleansing and debridement system; Osteoamp, an allograft-derived bone graft for orthopedic, neurosurgical, and reconstructive bone grafting procedures; Signafuse bone graft; Purebone, a natural osteoconductive scaffold; and Reficio demineralized bone matrix. The company’s restorative therapies include minimally invasive fracture treatments and rehabilitation products. Its products also include Exogen, an ultrasound bone stimulation system. The company sells its products to healthcare institutions, physicians, patients, distributors and dealers. Bioventus Inc. was founded in 2011 and is headquartered in Durham, North Carolina. Mehr anzeigen

Sektor
Healthcare
Branche
Medical Equipment & Supplies
Hauptsitz
Durham, United States
Gegründet
2026
Bioventus Inc is listed in the Healthcare sector of the NASDAQ with ticker BVS. The last closing price for Bioventus was US$9,04. Over the last year, Bioventus shares have traded in a share price range of US$ 5,81 to US$ 11,2493.

Bioventus currently has 67.748.048 shares in issue. The market capitalisation of Bioventus is US$598,89 million. Bioventus has a price to earnings ratio (PE ratio) of 22.43.

BVS Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.323.75586854468.529.217.819782718.43447886CS
4-1.68-15.96958174910.52117.817291359.23400307CS
120.0650.7407407407418.77511.24937.815550789.49604021CS
261.6923.63636363647.1511.24937.0154109928.98971429CS
522.0930.9629629636.7511.24935.813966888.00689446CS
1566.01212.3674911662.8314.382.693645587.59219598CS
260-8.74-49.715585893117.5819.94090.79993943196.62870169CS

BVS - Frequently Asked Questions (FAQ)

What is the current Bioventus Inc share price?
The current share price of Bioventus Inc is US$ 8,84
How many Bioventus Inc shares are in issue?
Bioventus Inc has 67.748.048 shares in issue
What is the market cap of Bioventus Inc?
The market capitalisation of Bioventus Inc is USD 598,89M
What is the 1 year trading range for Bioventus Inc share price?
Bioventus Inc has traded in the range of US$ 5,81 to US$ 11,2493 during the past year
What is the PE ratio of Bioventus Inc?
The price to earnings ratio of Bioventus Inc is 22,43
What is the cash to sales ratio of Bioventus Inc?
The cash to sales ratio of Bioventus Inc is 1,06
What is the registered address of Bioventus Inc?
The registered address for Bioventus Inc is 4721 Emperor Boulevard, Durham, North Carolina, 27703
What is the Bioventus Inc website address?
The website address for Bioventus Inc is www.bioventus.com
Which industry sector does Bioventus Inc operate in?
Bioventus Inc operates in the Medical Equipment & Supplies sector

BVS Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen